- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 26, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from MorningStar referenced a study published online ahead of print in the November 2024 issue of The American Journal of Managed Care®. The study, “Prescription Rebate Guarantees: Employer Insights,” focused on the role of employer benefits consultants and brokers in the selection of pharmacy benefit managers, as they may help in continuing the reliance on drug rebates, which are linked to higher list prices and higher out-of-pocket costs. Mark Cuban, owner of the Mark Cuban Cost Plus Drug Company, which buys and sells drugs at affordable prices, also shared the article on X.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL
April 3rd 2025In this comparative analysis, patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) received bridging therapy via radiation or systemic treatment while their chimeric antigen receptor T-cell therapy (CAR T) was being manufactured.
Read More
